tuberous sclerosis

Showing 1 - 25 of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Telomeric 22Q13 Monosomy Syndrome, Tuberous Sclerosis, Hamartoma Syndrome, Multiple Trial in Chicago (Functional Behavioral

Enrolling by invitation
  • Telomeric 22Q13 Monosomy Syndrome
  • +7 more
  • Functional Behavioral Training (FBT)
  • Positive Parenting Strategies-Treatment as Usual
  • Chicago, Illinois
    Autism Assessment Research Treatment and Services (AARTS) Center
Nov 14, 2023

Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder Trial in Canada (Sertraline, Placebo)

Not yet recruiting
  • Neurodevelopmental Disorders
  • +25 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 11, 2023

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting
  • Adenine Phosphoribosyltransferase Deficiency
  • +83 more
    • Bristol, South West, United Kingdom
      Zoe Plummer
    Sep 26, 2023

    Study of the Disease Process of Lymphangioleiomyomatosis

    Recruiting
    • Lung Disease
    • +3 more
    • Toshibia Aquilion One CT
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Study of Skin Tumors in Tuberous Sclerosis

    Recruiting
    • Tuberous Sclerosis
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Role of Genetic Factors in the Development of Lung Disease

      Recruiting
      • Cystic Fibrosis
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 21, 2023

        Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)

        Recruiting
        • Tuberous Sclerosis
        • Lymphangioleiomyomatosis
        • Phlebotomy
        • +3 more
        • Birmingham, Alabama
        • +22 more
        Jan 6, 2023

        Tuberous Sclerosis Trial in United States (GNX oral suspension, TID, Placebo)

        Recruiting
        • Tuberous Sclerosis
        • GNX oral suspension, TID
        • Placebo
        • Phoenix, Arizona
        • +36 more
        Oct 28, 2022

        Tuberous Sclerosis Trial in United States (Ganaxolone)

        Completed
        • Tuberous Sclerosis
        • Los Angeles, California
        • +6 more
        Oct 27, 2022

        Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )

        Completed
        • Facial Angiofibroma
        • Tuberous Sclerosis
        • Phoenix, Arizona
        • +16 more
        Jul 26, 2022

        Chronic Kidney Diseases, Diabetes, Arterial Hypertension Trial in Bari (KidneYou APP)

        Recruiting
        • Chronic Kidney Diseases
        • +12 more
        • KidneYou APP
        • Bari, Italy
          U.O. Nefrologia
        Jul 19, 2022

        Familial Investigations of Childhood Cancer Predisposition

        Recruiting
        • Acute Leukemia
        • +45 more
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          May 11, 2022

          Fragile X Syndrome, Angelman Syndrome, Prader-Willi Syndrome Trial in Research Triangle Park (Parent-Infant Inter(X)action

          Enrolling by invitation
          • Fragile X Syndrome
          • +13 more
          • Parent-Infant Inter(X)action Intervention (PIXI)
          • Research Triangle Park, North Carolina
            RTI International
          Feb 23, 2022

          Angiofibroma of Face, Tuberous Sclerosis Trial in China, United States (Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment)

          Recruiting
          • Angiofibroma of Face
          • Tuberous Sclerosis
          • Sirolimus 0.2%
          • +2 more
          • Phoenix, Arizona
          • +7 more
          Feb 2, 2022

          Data Set Re-use With Statistical Methodologies Tailored for

          Recruiting
          • Tuberous Sclerosis
          • Epilepsy
            • Paris, France
              Rima Nabbout
            Jan 5, 2022

            Autism Spectrum Disorder and Intellectual Disability

            Recruiting
            • Tuberous Sclerosis
            • +2 more
              • Birmingham, Alabama
              • +5 more
              Jul 29, 2021

              Tuberous Sclerosis Trial in Los Angeles, Boston (JASPER)

              Recruiting
              • Tuberous Sclerosis
              • JASPER
              • Los Angeles, California
              • +1 more
              Nov 5, 2020

              Angiofibromas, Tuberous Sclerosis Trial in Australia, United States (Placebo, Rapamycin)

              Completed
              • Angiofibromas
              • Tuberous Sclerosis
              • Birmingham, Alabama
              • +9 more
              Sep 30, 2020

              GROWing Up With Rare GENEtic Syndromes

              Recruiting
              • Prader-Willi Syndrome
              • +32 more
              • Retrospective file studies
              • Rotterdam, Zuid-Holland, Netherlands
                Erasmus Medical Center
              Jul 3, 2020

              Epilepsy, Focal Cortical Dysplasia, Tuberous Sclerosis Trial in Los Angeles, Montreal (Intra-operative brain tonometry)

              Recruiting
              • Epilepsy
              • +9 more
              • Intra-operative brain tonometry
              • Los Angeles, California
              • +1 more
              Apr 9, 2020

              Autistic Patients: Gene Networks and Clinical Subtypes

              Terminated
              • Autism
              • Tuberous Sclerosis
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center, 9000 Rockville Pi
                Dec 14, 2019

                Fasting on the Size of Abdominal Lymphatic Tumors in Women

                Completed
                • Lymphangioleiomyomas
                • +2 more
                  • Bethesda, Maryland
                    National Institutes of Health Clinical Center, 9000 Rockville Pi
                  Mar 5, 2019

                  Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule Trial in Suita, Osaka (NPC-12G gel)

                  Completed
                  • Tuberous Sclerosis
                  • +3 more
                  • NPC-12G gel
                  • Suita, Osaka, Japan
                    Graduate School of Medicine, Osaka University
                  Feb 18, 2019

                  Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome Trial in New York (Turmeric)

                  Withdrawn
                  • Epilepsy
                  • +4 more
                  • Turmeric
                  • New York, New York
                    New York University School of Medicine
                  Apr 26, 2018

                  Tuberous Sclerosis Trial in Cardiff (Placebo, Everolimus (RAD001))

                  Unknown status
                  • Tuberous Sclerosis
                  • Placebo
                  • Everolimus (RAD001)
                  • Cardiff, United Kingdom
                    Cardiff University
                  Jan 29, 2018